http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-122014024864-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a910d33c239980f3a705e312c5bad6a |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12 |
| filingDate | 2001-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03566b399ea1e7c596cdad5f937a6b2f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cfd1b21e15a782d73a99f8c1fff9f2e7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5581d5b4dda9f4bf3c3daa021a1b3a2d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_806aec21f9fa0c9ebaddc6a6f0aaddc5 |
| publicationDate | 2019-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-122014024864-B1 |
| titleOfInvention | PYRIMIDINE DERIVATIVE, PROCESS FOR PREPARING A PYRIMIDINE DERIVATIVE, PHARMACEUTICAL COMPOSITION, AND USE OF A PYRIMIDINE DERIVATIVE |
| abstract | "Pyrimidine derivative, process for preparing a pyrimidine derivative, pharmaceutical composition, and use of a pyrimidine derivative" (i) the pyrimidine derivatives of formula (1) wherein q1, q2, ge R1 are as defined herein and their pharmaceutically acceptable salts and in vivo hydrolysable esters are described. The processes for their manufacture, pharmaceutical compositions and their use as cyclin-dependent serine / threonine kinase (cdk) and focal adhesion kinase (fak) inhibitors are also described. |
| priorityDate | 2000-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 421.